Method of nanopore sequencing of concatenated nucleic acids

US12584170B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12584170-B2
Application numberUS-202117379931-A
CountryUS
Kind codeB2
Filing dateJul 19, 2021
Priority dateMay 25, 2016
Publication dateMar 24, 2026
Grant dateMar 24, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a new method of characterising two or more target polynucleotides using a pore. The method involves sequentially attaching to a first polynucleotide one or more subsequent polynucleotides to form a concatenated polynucleotide.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A population of polynucleotide adaptors comprising a first polynucleotide adaptor and a second polynucleotide adaptor, wherein the first polynucleotide adaptor and the second polynucleotide adaptor each comprise a first polynucleotide strand and a second polynucleotide strand, each strand having a 5′ end and a 3′ end, wherein: (a) a portion extending to the 3′ end of the first polynucleotide strand is complementary to a portion extending to the 5′ end of the second polynucleotide strand, and the complementary portions form a duplex; (b) a single stranded portion extending to the 5′ end of the first polynucleotide strand and a single stranded portion extending to the 3′ end of the second polynucleotide strand are not complementary and do not hybridise to one another; (c) the complementary portion extending to the 5′ end of the second polynucleotide strand of the first polynucleotide adaptor comprises a sequence that is capable, when the duplex is unwound, of hybridising to a sequence comprised in the single stranded portion extending to the 5′ end of the first polynucleotide strand of the second polynucleotide adaptor; and (d) the 5′ end of the first polynucleotide strand comprises a click reactive group and the 3′ end of the second polynucleotide strand comprises a complementary click reactive group. 2 . The population according to claim 1 , wherein a sequence comprised in the portion extending to the 5′ end of the second polynucleotide strand of the first polynucleotide adaptor and a sequence comprised in the single stranded portion extending to the 5′ end of the first polynucleotide strand of the second polynucleotide adaptor have a length of from 6 to 50 nucleotides. 3 . The population according to claim 1 , wherein one portion of a non-complementary region in the second polynucleotide strand of each polynucleotide adaptor forms a loop. 4 . The population according to claim 1 , wherein only one of the polynucleotide adaptors in the population comprises a molecular brake. 5 . The population according to claim 4 , wherein the molecular brake is or is derived from a polymerase, helicase, or exonuclease. 6 . The population according to claim 1 , wherein the duplex has a length of 6 to 200 base pairs. 7 . The population according to claim 1 , wherein the duplex comprises a blocker. 8 . The population according to claim 7 , wherein the blocker comprises iSp18. 9 . The population according to claim 1 , wherein the single stranded portion extending to the 5′ end of the first polynucleotide strand comprises a single stranded leader sequence. 10 . The population according to claim 9 , wherein the leader sequence is 10 to 150 nucleotides in length. 11 . The population according to claim 1 , wherein each polynucleotide adapter comprises one or more polynucleotide binding proteins. 12 . The population according to claim 11 , wherein the one or more polynucleotide binding proteins is attached to the first polynucleotide strand of each polynucleotide adapter. 13 . The population according to claim 1 , wherein each polynucleotide adaptor comprises one or more anchors. 14 . The population according to claim 13 , wherein the one or more anchors is cholesterol. 15 . A population of polynucleotide adaptors comprising a first polynucleotide adaptor and a second polynucleotide adaptor, wherein the first polynucleotide adaptor and the second polynucleotide adaptor each comprise a first polynucleotide strand and a second polynucleotide strand, each strand having a 5′ end and a 3′ end, wherein: (a) a portion extending to the 3′ end of the first polynucleotide strand is complementary to a portion extending to the 5′ end of the second polynucleotide strand, and the complementary portions form a duplex; (b) a single stranded portion extending to the 5′ end of the first polynucleotide strand and a single stranded portion extending to the 3′ end of the second polynucleotide strand are not complementary and do not hybridise to one another; (c) the complementary portion extending to the 5′ end of the second polynucleotide strand of the first polynucleotide adaptor comprises a sequence that is capable, when the duplex is unwound, of hybridising to a sequence comprised in the single stranded portion extending to the 5′ end of the first polynucleotide strand of the second polynucleotide adaptor; and (d) the 5′ end of the first polynucleotide strand comprises a phosphatase. 16 . A kit for characterising two or more double stranded target polynucleotides, comprising the population of polynucleotide adaptors according to claim 1 and one or more of the following: a population of hairpin loops; a microparticle; one or more anchors capable of coupling a polynucleotide to a membrane; membrane components; and a magnet or electromagnet. 17 . The kit according to claim 16 , wherein the membrane components comprise components of an amphiphilic layer or a triblock copolymer membrane. 18 . The kit according to claim 16 , wherein the kit further comprises a transmembrane protein pore.

Assignees

Inventors

Classifications

  • Libraries containing nucleotides or polynucleotides, or derivatives thereof · CPC title

  • Hairpin oligonucleotides · CPC title

  • General methods of preparing gene libraries, not provided for in other subgroups · CPC title

  • Methods for sequencing · CPC title

  • C12Q1/6874Primary

    involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12584170B2 cover?
The invention relates to a new method of characterising two or more target polynucleotides using a pore. The method involves sequentially attaching to a first polynucleotide one or more subsequent polynucleotides to form a concatenated polynucleotide.
Who is the assignee on this patent?
Oxford Nanopore Tech Plc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6874. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).